{{Rsnum
|rsid=12418451
|Chromosome=11
|position=69167951
|Orientation=plus
|GMAF=0.1589
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=RP11-554A11.8
|Gene_s=RP11-554A11.8
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.0 | 48.3 | 41.7
| HCB | 0.0 | 6.8 | 93.2
| JPT | 0.0 | 6.7 | 93.3
| YRI | 0.0 | 7.9 | 92.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 6.8 | 93.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19505914
|Title=Two independent prostate cancer risk-associated Loci at 11q13
|OA=1
}}

{{PMID Auto
|PMID=21531787
|Title=Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer
|OA=1
}}

{{PMID Auto
|PMID=22459122
|Title=Interactions Between Genome-wide Significant Genetic Variants and Circulating Concentrations of Insulin-like Growth Factor 1, Sex Hormones, and Binding Proteins in Relation to Prostate Cancer Risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
|OA=1
}}
{{PMID|19434657|OA=1
}} Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.

{{PMID|19549807|OA=1
}} Prostate cancer risk associated loci in African Americans.

{{PMID|21071540|OA=1
}} Validation of genome-wide prostate cancer associations in men of African descent.

{{PMID|21390317|OA=1
}} Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.

{{PMID|22219177|OA=1
}} A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}